Search Results - "Rudolph, Gerda"
-
1
Effect of high‐dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis
Published in Hepatology (Baltimore, Md.) (01-09-2004)“…Ursodeoxycholic acid (UDCA) has beneficial effects in cholestatic liver diseases. In primary sclerosing cholangitis (PSC), there is evidence that high doses…”
Get full text
Journal Article -
2
Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis
Published in Journal of hepatology (01-07-2009)“…Background/Aims In primary sclerosing cholangitis (PSC) dominant stenoses are frequently associated with bacterial, and in part, also fungal infections of the…”
Get full text
Journal Article -
3
Microbiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies
Published in Medicine (Baltimore) (01-03-2016)“…The aim of this study was to determine the antibiotic susceptibility profiles of bacteria in bile samples and to analyze the clinical relevance of the findings…”
Get full text
Journal Article -
4
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival
Published in Journal of hepatology (01-08-2010)“…Background & Aims In patients with primary sclerosing cholangitis (PSC) treated with ursodeoxycholic acid (UDCA), dominant stenoses are associated with reduced…”
Get full text
Journal Article -
5
Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment
Published in Gastrointestinal endoscopy (01-03-2010)“…Background Primary sclerosing cholangitis is characterized by progressive fibrotic inflammation and obliteration of intra- and/or extrahepatic bile ducts…”
Get full text
Journal Article -
6
Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment
Published in Journal of hepatology (01-02-2002)“…Background / Aims : Primary sclerosing cholangitis is characterized by progressive fibrotic inflammation and obliteration of intra- and/or extrahepatic bile…”
Get full text
Journal Article -
7
Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation
Published in Endoscopy (01-11-2013)“…To determine the importance of bacteriobilia and fungibilia in patients with endoscopic treatment of biliary complications after orthotopic liver…”
Get more information
Journal Article -
8
Biliary candida infections in primary sclerosing cholangitis
Published in Journal of hepatology (01-11-2006)“…Patients with Primary Sclerosing Cholangitis (PSC) frequently develop dominant stenoses of the bile ducts and bacterial infections represent a major problem in…”
Get full text
Journal Article -
9
The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid
Published in European journal of gastroenterology & hepatology (01-06-2007)“…BACKGROUND/AIMSCholangiocarcinoma represents a serious complication of primary sclerosing cholangitis. Ursodeoxycholic acid may possibly influence the…”
Get full text
Journal Article -
10
Biliary and urinary excretion of sulfated, glucuronidated and tetrahydroxylated bile acids in cirrhotic patients
Published in Hepatology (Baltimore, Md.) (01-05-1985)“…In patients with hepatobiliary diseases, considerable amounts of sulfated and glucuronidated bile acids are excreted in urine. Information on the biliary…”
Get more information
Journal Article -
11
M1954 In PSC With Colitis, Long-Time UDCA is Associated With a Reduction of Colonic Cacrcinomas
Published in Gastroenterology (New York, N.Y. 1943) (2010)Get full text
Journal Article -
12
-
13
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis: An 8-year prospective study
Published in Journal of hepatology (1997)“…Background/Aims: Primary sclerosing cholangitis is characterized by progressive fibrotic inflammation and obliteration of intra- and extrahepatic bile ducts…”
Get full text
Journal Article -
14
Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period
Published in Journal of hepatology (01-01-1994)“…Primary sclerosing cholangitis is a cholestatic disease of the liver characterized by progressive fibrotic inflammation and obliteration of the extra- and/or…”
Get more information
Journal Article -
15
Biliary secretion of bile acids and lipids in primary sclerosing cholangitis.Influence of cholestasis and effect of ursodeoxycholic acid treatment
Published in Journal of hepatology (1995)“…In patients with primary sclerosing cholangitis cholestasis is a prominent feature of the disease. We studied the effect of cholestasis and of ursodeoxycholic…”
Get full text
Journal Article -
16
Influence of the enterohepatic circulation on the intestinal absorption of tauro-ursodeoxycholic acid in man
Published in Gastroenterology (New York, N.Y. 1943) (01-04-2001)Get full text
Journal Article -
17
Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis
Published in Hepatology (Baltimore, Md.) (01-06-1993)“…Treatment of patients with cholestatic liver diseases with ursodeoxycholic acid has been shown to have beneficial effects that may be related to a shift in the…”
Get more information
Journal Article -
18
Influence of cholestasis on absorption of ursodeoxycholic acid
Published in Digestive diseases and sciences (01-04-1999)“…Ursodeoxycholic acid (UDCA) has beneficial effects in cholestatic liver diseases. Absorption of UDCA is slow and incomplete. In the present study the effect of…”
Get full text
Journal Article -
19
Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage
Published in Gastroenterology (New York, N.Y. 1943) (01-03-1992)“…Ursodeoxycholic acid (UDCA) dissolves cholesterol gallstones and improves liver function test results in patients with cholestatic liver diseases. Its…”
Get more information
Journal Article -
20
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis
Published in Hepatology (Baltimore, Md.) (01-09-1990)“…Ursodeoxycholic acid treatment of patients with primary biliary cirrhosis may lead to relief of pruritus and improvement of biochemical liver tests. The…”
Get more information
Journal Article